Facebook Google Twitter LinkedIn Youtube Instagram Pinterest Website Write A Review View more reviews Rating and Reviews Alternate business Name Address Landmark Time IFSC Distance Alternate Business Name W 3Words checkbox-checked Call Direction Star Full Star Empty Start Half QR Scan QR Enlarge Email Search WhatsApp Nearby Location Faq Plus Faq Minus Next Arrow Prev Arrow Facebook Google Twitter LinkedIn Youtube Instagram Pinterest About Review About Rating About Plus Code About Tags About Establishment About Nearby Locality About Parking Option About Payment Method About Other Store About Business Hours About Category About QR Code About Service Tiktok Parking List Icon Payment List Icon Callback Icon

Open a Demat Account & Start Trading!

Write to us with your query and we shall get back

Motilal Oswal Financial Services Limited

1st Floor
Main Bazar
Firozpur - 152002
Opposite Mohalla Budhwara

Discover More With Us

Tell us about your experience.
Scan this QR code to discover more with us.
Download QR

Store Ratings

Social Timeline

1) Cadila Healthcare Q2FY21 net profit jumped over four-fold to Rs 473.4 crore. The company had posted a net profit of Rs 107.2 crore for the same period of last FY. Consolidated total revenue from operations of the company stood at Rs 3,820 crore. The net debt as on 30th Sept, 2020 stood at Rs 4,031 crore against Rs 6,740. crore as on 31st Mar, 2020. 2) India October Manufacturing PMI reported 12 years high. Germany reported 8-month high October PMI. US reported PMI for manufacturing registered 59.3% in October, the highest level since September 2018. Expect positive for metal stocks ahead of strong demand.  #MOMarketUpdates #MotilalOswal #IndianStockMarket #stockinvesting #Cadila #steel #sensex #nifty #stocktips

Posted On: 03 Nov 2020 4:57 PM

The Pharma stocks are positive due to multiple approvals of US FDA for different medicines. The companies are also manufacturing the drugs for the primary treatment of Covid-19. Dr Reddy's Laboratories reclaimed the tag of being the second most valuable listed pharmaceutical company. Sun Pharma is the most valued listed company of India with the market cap of Rs 1.26lakh cr. With a favourable ruling in the appeals court, the odds of launching gVascepa also rise considerably. Bristol Myers Squibb had inked a patent settlement with Dr. Reddy’s Laboratories, allowing the Indian generics company to start with a “volume-limited” launch sometime after March 2022. The exact date of the rollout, and amount of generic Revlimid Dr. Reddy’s will be allowed to sell, are confidential. But on January 31, 2026, the company will have a license to sell its generic Revlimid with no limits. #MOMarketUpdates #IndianStockMarket #MotilalOswal #NiftyPharma #NSE #BSE #Recommendation #Stocktip #Stockrecommendation

Posted On: 18 Sep 2020 5:44 PM
{"83660":"https:\/\/stockbroker.motilaloswal.com\/motilal-oswal-financial-services-limited-stock-broker-main-bazar-firozpur-77646\/TimelineDetails\/83660","77408":"https:\/\/stockbroker.motilaloswal.com\/motilal-oswal-financial-services-limited-stock-broker-main-bazar-firozpur-77646\/TimelineDetails\/77408"}